BMS signs over Reyataz know-how to Brazilian government
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb and Brazil's health ministry have signed a technology transfer deal that will see the firm hand over the know-how to producing its antiretroviral Reyataz (atazanavir). The agreement means that the Brazilian government will be able to produce enough of the drug to meet local demand.